Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Name: Prothena Corporation plc: Is Infosys Ltd. worth buying?
Item: Prothena Corporation plc
Rating: 1.83150
Author: Trendlyne DVM scores

about

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

9.93 -0.25 (-2.46%)

43.77% Fall from 52W High

504.4K

XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

14.5 / 100

Technically Neutral

58.8 / 100

1Yr Price target upside is 85%

6 analysts

Prothena Corporation plc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Prothena Corporation plc Live Stock Price Today, Share Analysis and Chart

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseas...

43.77% Fall from 52W High

SWOT Analysis

Prothena Corporation plc Live Price Chart